Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
Authors:
- Denis N. KisakovDenis N. Kisakov
- Larisa I. KarpenkoLarisa I. Karpenko
- Lyubov A. KisakovaLyubov A. Kisakova
- Sergey V. SharabrinSergey V. Sharabrin
- Mariya B. BorgoyakovaMariya B. Borgoyakova
- Ekaterina V. StarostinaEkaterina V. Starostina
- Oleg S. TaranovOleg S. Taranov
- Elena K. IvlevaElena K. Ivleva
- Oleg V. PyankovOleg V. Pyankov
- Anna V. ZaykovskayaAnna V. Zaykovskaya
- Elena V. DmitrienkoElena V. Dmitrienko
- Vladimir A. YakovlevVladimir A. Yakovlev
Open Access
Abstract
Background: Although mRNA vaccines encapsulated in lipid nanoparticles (LNPs) have demonstrated a safety profile with minimal serious adverse events in clinical trials, there is opportunity to further reduce mRNA reactogenicity. The development of naked mRNA vaccines could improve vaccine tolerability. Naked nucleic acid delivery using the jet injection method may be a solution. Methods: In the first part of the study, the optimal conditions providing low traumatization and high expression of the model mRNA-GFP molecule in the tissues of laboratory animals were determined. Then, we used the selected protocol to immunize BALB/c mice with mRNA-RBD encoding the SARS-CoV-2 receptor-binding domain (RBD). It was demonstrated that mice vaccinated with naked mRNA-RBD developed a high level of specific antibodies with virus-neutralizing activity. The vaccine also induced a strong RBD-specific T-cell response and reduced the viral load in the lungs of the animals after infection with the SARS-CoV-2 virus. The level of immune response in mice immunized with mRNA-RBD using a spring-loaded jet injector was comparable to that in animals immunized with mRNA-RBD encapsulated in LNPs. Results: In this study, the efficacy of an inexpensive, simple, and safe method of mRNA delivery using a spring-loaded jet injector was evaluated and validated. Conclusions: Our findings suggest that the jet injection method may be a possible alternative to LNPs for delivering mRNA vaccines against SARS-CoV-2 infection.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (Contract No. 075-15-2019-1665)
This publication has 73 references indexed in Scilit:
- Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunityiScience, 2023
- Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing CancerPharmaceutical Research, 2022
- Simultaneous quantification of multiple RNA cargos co-loaded into nanoparticle-based delivery systemsInternational Journal of Pharmaceutics, 2022
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative reviewClinical Microbiology and Infection, 2021
- Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugsInternational Journal of Pharmaceutics, 2021
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stabilityInternational Journal of Pharmaceutics, 2021
- mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested ApproachThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARSCell, 2020
- Alternative vaccine delivery methods2013
- Sendai virus vectors as an emerging negative‐strand RNA viral vector systemThe Journal of Gene Medicine, 2003